Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD). Currently, two antifibrotic drugs are available for reducing forced vital capacity (FVC) decline in IPF. However, many pulmonologists wait before initiating treatment, especially when IPF pati...

詳細記述

書誌詳細

主要な著者:	Yuya Aono, Yutaro Nakamura, Masato Kono, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Mikio Toyoshima, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
フォーマット:	Artigo
言語:	Inglês
出版事項:	SAGE Publishing 2020-09-01
シリーズ:	Therapeutic Advances in Respiratory Disease
オンライン･アクセス:	https://doi.org/10.1177/1753466620953783
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!